Molecular Modeling in Drug Design
This book is a printed edition of the Special Issue Molecular Modeling in Drug Design that was published in Molecules
Saved in:
: | |
---|---|
Year of Publication: | 2019 |
Language: | English |
Physical Description: | 1 electronic resource (220 p.) |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
LEADER | 03259nam-a2201045z--4500 | ||
---|---|---|---|
001 | 993544034404498 | ||
005 | 20231214133435.0 | ||
006 | m o d | ||
007 | cr|mn|---annan | ||
008 | 202102s2019 xx |||||o ||| 0|eng d | ||
035 | |a (CKB)4920000000095246 | ||
035 | |a (oapen)https://directory.doabooks.org/handle/20.500.12854/53851 | ||
035 | |a (EXLCZ)994920000000095246 | ||
041 | 0 | |a eng | |
100 | 1 | |a Wade, Rebecca |4 auth | |
245 | 1 | 0 | |a Molecular Modeling in Drug Design |
260 | |b MDPI - Multidisciplinary Digital Publishing Institute |c 2019 | ||
300 | |a 1 electronic resource (220 p.) | ||
336 | |a text |b txt |2 rdacontent | ||
337 | |a computer |b c |2 rdamedia | ||
338 | |a online resource |b cr |2 rdacarrier | ||
520 | |a This book is a printed edition of the Special Issue Molecular Modeling in Drug Design that was published in Molecules | ||
546 | |a English | ||
653 | |a metadynamics | ||
653 | |a natural compounds | ||
653 | |a virtual screening | ||
653 | |a probe energies | ||
653 | |a molecular dynamics simulation | ||
653 | |a human ecto-5?-nucleotidase | ||
653 | |a neural networks | ||
653 | |a quantitative structure-activity relationship (QSAR) | ||
653 | |a artificial intelligence | ||
653 | |a allosterism | ||
653 | |a in silico screening | ||
653 | |a drug discovery | ||
653 | |a amyloid fibrils | ||
653 | |a mechanical stability | ||
653 | |a adenosine receptors | ||
653 | |a adenosine receptor | ||
653 | |a ligand binding | ||
653 | |a promiscuous mechanism | ||
653 | |a AutoGrid | ||
653 | |a dynamic light scattering | ||
653 | |a resultant dipole moment | ||
653 | |a density-based clustering | ||
653 | |a Alzheimer’s disease | ||
653 | |a drug design | ||
653 | |a biophenols | ||
653 | |a enzymatic assays | ||
653 | |a all-atom molecular dynamics simulation | ||
653 | |a fragment screening | ||
653 | |a adenosine | ||
653 | |a docking | ||
653 | |a molecular docking | ||
653 | |a cosolvent molecular dynamics | ||
653 | |a turbidimetry | ||
653 | |a squalene synthase (SQS) | ||
653 | |a molecular recognition | ||
653 | |a protein-peptide interactions | ||
653 | |a extracellular loops | ||
653 | |a FimH | ||
653 | |a binding affinity | ||
653 | |a rational drug design | ||
653 | |a de novo design | ||
653 | |a hyperlipidemia | ||
653 | |a AR ligands | ||
653 | |a aggregation | ||
653 | |a property prediction | ||
653 | |a PPI inhibition | ||
653 | |a deep learning | ||
653 | |a proteins | ||
653 | |a quantitative structure-property prediction (QSPR) | ||
653 | |a protein protein interactions | ||
653 | |a boron cluster | ||
653 | |a target-focused pharmacophore modeling | ||
653 | |a ligand–protofiber interactions | ||
653 | |a structure-based drug design | ||
653 | |a scoring function | ||
653 | |a grid maps | ||
653 | |a solvent effect | ||
653 | |a adhesion | ||
653 | |a molecular dynamics | ||
653 | |a Traditional Chinese Medicine | ||
653 | |a steered molecular dynamics | ||
653 | |a interaction energy | ||
653 | |a EphA2-ephrin A1 | ||
653 | |a molecular modeling | ||
653 | |a method development | ||
776 | |z 3-03897-614-8 | ||
700 | 1 | |a Salo-Ahen, Outi |4 auth | |
906 | |a BOOK | ||
ADM | |b 2023-12-15 05:54:02 Europe/Vienna |f system |c marc21 |a 2019-11-10 04:18:40 Europe/Vienna |g false | ||
AVE | |i DOAB Directory of Open Access Books |P DOAB Directory of Open Access Books |x https://eu02.alma.exlibrisgroup.com/view/uresolver/43ACC_OEAW/openurl?u.ignore_date_coverage=true&portfolio_pid=5337522940004498&Force_direct=true |Z 5337522940004498 |b Available |8 5337522940004498 |